Optimal timing of non-pharmaceutical interventions during an epidemic

被引:7
|
作者
Huberts, Nick F. D. [1 ]
Thijssen, Jacco J. J. [1 ,2 ]
机构
[1] Univ York, Management Sch, York YO10 5ZF, England
[2] Univ York, Dept Math, York YO10 5ZF, England
关键词
Decision analysis; Continuous -time Markov chains; SIRD model; COVID-19; Optimal stopping; PUBLIC-HEALTH INTERVENTIONS; REAL OPTIONS; OPTIMAL OPERATION; INVESTMENT; VALUATION; DECISIONS; PLANTS; MODEL;
D O I
10.1016/j.ejor.2022.06.034
中图分类号
C93 [管理学];
学科分类号
12 ; 1201 ; 1202 ; 120202 ;
摘要
In response to the recent outbreak of the SARS-CoV-2 virus governments have aimed to reduce the virus's spread through, inter alia, non-pharmaceutical intervention. We address the question when such mea-sures should be implemented and, once implemented, when to remove them.These issues are viewed through a real-options lens and we develop an SIRD-like continuous-time Markov chain model to analyze a sequence of options: the option to intervene and introduce measures and, after intervention has started, the option to remove these. Measures can be imposed multiple times.We implement our model using estimates from empirical studies and, under fairly general assumptions, our main conclusions are that: (1) measures should be put in place not long after the first infections occur; (2) if the epidemic is discovered when there are many infected individuals already, then it is optimal never to introduce measures; (3) once the decision to introduce measures has been taken, these should stay in place until the number of susceptible or infected members of the population is close to zero; (4) it is never optimal to introduce a tier system to phase-in measures but it is optimal to use a tier system to phase-out measures; (5) a more infectious variant may reduce the duration of measures being in place; (6) the risk of infections being brought in by travelers should be curbed even when no other measures are in place. These results are robust to several variations of our base-case model.(c) 2022 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license ( http://creativecommons.org/licenses/by/4.0/ )
引用
收藏
页码:1366 / 1389
页数:24
相关论文
共 50 条
  • [41] Environmental Indicator for COVID-19 Non-Pharmaceutical Interventions
    Lian, Xinbo
    Huang, Jianping
    Zhang, Li
    Liu, Chuwei
    Liu, Xiaoyue
    Wang, Lina
    GEOPHYSICAL RESEARCH LETTERS, 2021, 48 (02)
  • [42] Optimal non-pharmaceutical interventions considering limited healthcare system capacity and economic costs in the Republic of Korea
    Lim, Yuna
    Ko, Youngsuk
    Mendoza, Victoria May P.
    Mendoza, Renier
    Lee, Jongmin
    Jung, Eunok
    MATHEMATICAL MODELLING OF NATURAL PHENOMENA, 2024, 19
  • [43] Influence of non-pharmaceutical interventions on epidemiological characteristics of Mycoplasma pneumoniae infection in children during and after the COVID-19 epidemic in Ningbo, China
    Jiang, Min
    Zhang, Hui
    Yao, Fangfang
    Lu, Qinhong
    Sun, Qian
    Liu, Zhen
    Li, Qingcao
    Wu, Guangliang
    FRONTIERS IN MICROBIOLOGY, 2024, 15
  • [44] Non-pharmaceutical interventions and urban vehicle mobility in Seoul during the COVID-19 pandemic
    Sung, Hyungun
    CITIES, 2022, 131
  • [45] Inferring the effective start dates of non-pharmaceutical interventions during COVID-19 outbreaks
    Kohanovski, Ilia
    Obolski, Uri
    Ram, Yoav
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2022, 117 : 361 - 368
  • [46] The methodologies to assess the effectiveness of non-pharmaceutical interventions during COVID-19: a systematic review
    Banholzer, Nicolas
    Lison, Adrian
    Ozcelik, Dennis
    Stadler, Tanja
    Feuerriegel, Stefan
    Vach, Werner
    EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2022, 37 (10) : 1003 - 1024
  • [47] Trends in gastrointestinal infections before and during non-pharmaceutical interventions in Korea in comparison with the United States
    Kim, Soyeoun
    Kim, Jinhyun
    Choi, Bo Youl
    Park, Boyoung
    EPIDEMIOLOGY AND HEALTH, 2022, 44
  • [48] The methodologies to assess the effectiveness of non-pharmaceutical interventions during COVID-19: a systematic review
    Nicolas Banholzer
    Adrian Lison
    Dennis Özcelik
    Tanja Stadler
    Stefan Feuerriegel
    Werner Vach
    European Journal of Epidemiology, 2022, 37 : 1003 - 1024
  • [49] Investigating the role of non-pharmaceutical interventions (NPI) during pandemics: COVID-19 as an example
    Abiri, Elaheh
    Raesi, Rasoul
    Kashani, Maryam Haji Ghasem
    BMC RESEARCH NOTES, 2025, 18 (01)
  • [50] The impact of non-pharmaceutical interventions on COVID-19 cases in South Australia and Victoria
    Milazzo, Adriana
    Giles, Lynne
    Parent, Natalie
    McCarthy, Sophie
    Laurence, Caroline
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PUBLIC HEALTH, 2022, 46 (04) : 482 - 487